We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
165 hedge funds and large institutions have $820M invested in Arcturus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 52 increasing their positions, 55 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
157% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 14
28% more capital invested
Capital invested by funds: $643M → $820M (+$177M)
14% more funds holding
Funds holding: 145 → 165 (+20)
2.91% more ownership
Funds ownership: 94.42% → 97.34% (+2.9%)
1% less call options, than puts
Call options by funds: $9.75M | Put options by funds: $9.89M
5% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 55
Holders
165
Holders Change
+20
Holders Change %
+13.79%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
52
Reduced
55
Closed
14
Calls
$9.75M
Puts
$9.89M
Net Calls
-$142K
Net Calls Change
+$792K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$14M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$7M |
| 3 |
BlackRock
New York
|
+$6.19M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$4.92M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$3.98M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.55M |
| 2 |
Renaissance Technologies
New York
|
-$4.03M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.51M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$3.11M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.86M |
